文献速递慢性肾脏病遗传性与小管间质肾病

ALDH1A1调控PD-L1转录及双硫仑联合PD-L1免疫治疗协同延缓ADPKD囊肿生长

Aldehyde dehydrogenase 1 A1 regulates the transcription of PD-L1 and its targeting with disulfiram together with PD-L1 immunotherapy synergistically delays cyst growth in ADPKD.
PubMed 文献 · Kidney Int · 2025-12-15

在Pkd1突变小鼠中,ALDH1A1在ADPKD肾脏中上调,通过转录调控Pd-l1和Ccl2影响免疫监视与巨噬细胞募集,并激活AKT、S6、STAT3、Rb等通路。敲除Aldh1A1或用双硫仑抑制ALDH1A1可延缓囊肿生长,与PD-L1抗体联用具有协同效应。

要点

  • ALDH1A1在ADPKD肾脏中上调,促进囊肿上皮细胞增殖。
  • 双硫仑抑制ALDH1A1可延缓两种Pkd1突变小鼠模型的囊肿生长。
  • 双硫仑联合PD-L1抗体协同延缓Pkd1突变小鼠肾脏囊肿生长。

核心结论

  • ALDH1A1在ADPKD中上调并作为转录因子调控Pd-l1和Ccl2,抑制ALDH1A1可延缓囊肿生长,与PD-L1抗体联用具有协同效应。

研究设计与样本

  • 在Pkd1突变小鼠中敲除Aldh1A1或用双硫仑抑制ALDH1A1,单独或联合PD-L1抗体,采用免疫染色、Western blot、qRT-PCR、流式细胞术、CUT-Tag和CHIP分析。

主要发现

  • ALDH1A1在ADPKD肾脏中上调,激活AKT、S6、STAT3和Rb等PKD相关信号通路,可能由AURKA介导以增加囊肿肾上皮细胞增殖。
  • 敲除Aldh1A1延缓Pkd1突变肾脏囊肿生长;ALDH1A1作为转录因子靶向多种基因,上调的ALDH1A1调控Pd-l1和Ccl2转录以影响PD-L1介导的免疫监视和巨噬细胞募集。
  • 双硫仑抑制ALDH1A1减少侵袭性(Pkd1nl/nl)和温和型(Pkd1RC/RC)Pkd1小鼠模型的囊肿生长。
  • 靶向ALDH1A1联合PD-L1抗体在Pkd1突变小鼠肾脏中对延缓囊肿生长具有协同效应。

临床怎么用

  • 双硫仑可能是ADPKD的有前景治疗药物,化疗联合免疫治疗(PD-L1抗体)是ADPKD治疗的新策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited kidney disease with no effective therapy to halt its progression. ALDH1A1, one of the aldehyde dehydrogenases, is the main ALDH1 isozyme known to oxidize 9-cis retinaldehyde into 9-cis retinoic acid, which can regulate the expression of the PKD1 gene. However, the role and mechanisms of ALDH1A1 in ADPKD remains elusive. METHODS: To investigate this, Aldh1A1 was knocked out and ALDH1A1 inhibited with disulfiram (DSF) either alone or together with PD-L1 antibody in Pkd1 mutant mice. The effect of ALDH1A1 on cyst growth, immune response and PKD associated signaling pathways as well as the target genes of ALDH1A1 was determined by immunostaining, Western blot, qRT-PCR, flow cytometry, CUT-Tag analysis, and CHIP assay. RESULTS: ALDH1A1 was upregulated in ADPKD kidneys, leading to an activation of PKD associated signaling pathways, including AKT, S6, STAT3 and Rb. This was possibly mediated by AURKA, to increase cystic kidney epithelial cell proliferation. Knockout of Aldh1A1 delayed cyst growth in Pkd1 mutant kidneys. ALDH1A1 functions as a transcription factor to target diverse genes as examined by CUT-Tag analysis. Elevated ALDH1A1 regulated the transcription of Pd-l1 and Ccl2 to affect PD-L1 mediated immune surveillance and recruitment of macrophages, respectively. Inhibiting ALDH1A1 with DSF decreased cyst growth in aggressive (Pkd1nl/nl) and mild (Pkd1RC/RC) Pkd1 mouse models. Additionally, targeting ALDH1A1 in combination with PD-L1 antibody had a synergistic effect on delaying cyst growth in Pkd1 mutant mouse kidneys. CONCLUSIONS: Our study suggests that DSF is a promising agent for ADPKD treatment and highlights novel therapeutic strategies by the combination of chemotherapy with immunotherapy in ADPKD treatment.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Cheng AS, Li LX, Zhou JX, et al. Aldehyde dehydrogenase 1 A1 regulates the transcription of PD-L1 and its targeting with disulfiram together with PD-L1 immunotherapy synergistically delays cyst growth in ADPKD. Kidney Int. 2025. PMID: 41407012. doi:10.1016/j.kint.2025.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。